Back to discover
Disease
Chondrocalcinosis
Late-stage therapeutic developmentEmerging research
1
Publications
1
Clinical trials
2017
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2017-01-01Kidney international
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
1
0
1
1
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Major themes1
- Dietary Supplements1
Leading journals1
- Kidney international1
Leading researchers8
- Blanchard A1
- Bockenhauer D1
- Bolignano D1
- Calò LA1
- Cosyns E1
- Devuyst O1
- Ellison DH1
- Karet Frankl FE1
Affiliations (unnormalised)6
- Center for Molecular Medicine1
- Centre d'Investigation Clinique1
- Centre for Nephrology1
- Institute of Clinical Physiology1
- Institute of Physiology1
- Oregon Health and Science University1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Presence of CALCIUM PYROPHOSPHATE in the connective tissues such as the cartilaginous structures of joints. When accompanied by GOUT-like symptoms, it is referred to as pseudogout.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.